常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
2.78/3.60
|
|
企業價值
123.96B
|
| 資產負債 |
|
每股賬面淨值
10.93
|
| 現金流量 |
|
現金流量率
0.09
|
| 損益表 |
|
收益
21.41B
|
|
每股收益
18.04
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV. |

55.51 
